hGH fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-05-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
== Dominican studies == Peukert was fluent in Spanish, and was very interested in the history of Latin America, especially the Dominican Republic, which he spent much of the late 1980s visiting. As the name Detlev is hard for Spanish speakers to pronounce, Peukert took to calling himself "Julio" Peukert. Peukert was interested in youth policy in the Dominican Republic and spent much time in the barrios (slums) of Santo Domingo working as a volunteer helping poor teenagers. In 1986, Peuket published a book in Spanish Anhelo de Dependencia Las Ofertas de Anexion de la Republica Dominicana a los Estados Unidos en siglo XIX about the debate concerning American plans to annex the Dominican Republic in the 19th century. Always a politically engaged historian, Peukert engaged in city planning for Santo Domingo and criticized the Dominican government for not doing more to help with the problems of poverty. At the time of his death, Peukert had begun writing a biography of the Dominican dictator General Rafael Trujillo.
Their vows make everyone forget the "dire situation" for a moment, until Ari suddenly collapses. Ari succumbs to the cancer and his death aired on 7 March 2022. After the episode was broadcast aired, Kipa-Williams took to his Instagram account to post a thank you message to the show's cast, crew, and fans for their support. He said "This Iconic Ozzie TV show took risks. I'm honoured to have co-created Māori cultural storylines, and will forever be proud of those scenes that made it to screen.. it was true teamwork.. My hope is this opens the door for more diversity. Thank you for everything Ariki Wiremu Parata, you taught me a lot. I'm gonna miss you." The character made one final appearance on 15 March 2022, as Ari appears to Mia in a dream. The following year, Kipa-Williams revealed that he quit Home and Away because of "a calling" to the Māori culture. He moved back to Aotearoa, where he bought a farm and began lessons in te reo in order to become more fluent in the language.
The large intestine forms an arch starting at the cecum and ending at the rectum and anal canal. It also includes the appendix, which is attached to the cecum. Its length is about 1.5 m, and the area of the mucosa in an adult human is about 2 m2 (22 sq ft). The longest part of the large intestine is the colon whose main function is to absorb water and salts. The large intestine begins at the cecum, where the appendix is located. This is also the start of the colon as the ascending colon in the back wall of the abdomen. At the right colic flexure (hepatic flexure) (the flexed portion of the ascending and transverse colon) it runs across the abdomen in the transverse colon, passing below the diaphragm. At the left colic flexure (splenic flexure) the flexed portion of the transverse and descending colon, it descends down the left side of the abdomen. It reaches the sigmoid colon which is a loop of the colon closest to the rectum and continues to the rectum and anal canal.
There is no cure for muscular dystrophy. In terms of management, physical therapy, occupational therapy, orthotic intervention (e.g., ankle-foot orthosis), speech therapy, and respiratory therapy may be helpful. Low-intensity corticosteroids such as prednisone, and deflazacort may help to maintain muscle tone. Orthoses (orthopedic appliances used for support) and corrective orthopedic surgery may be needed to improve the quality of life in some cases. The cardiac problems that occur with Emery–Dreifuss muscular dystrophy (EDMD) and myotonic muscular dystrophy may require a pacemaker. The myotonia (delayed relaxation of a muscle after a strong contraction) occurring in myotonic muscular dystrophy may be treated with medications such as quinine. Low-intensity assisted exercises, dynamic exercise training, or assisted bicycle training of the arms and legs during a 24-week trial were shown to significantly delay the functional loss of muscular dystrophy. These therapies may be performed in a safe and feasible manner, even for children in their ambulation stages. However, eccentric or intense exercises causing soreness should not be used, as they can cause further damage. Occupational therapy assists the patient to engage in activities of daily living (such as self-feeding and self-care activities) and leisure activities at the most independent level possible. This may be achieved with use of adaptive equipment or the use of energy-conservation techniques.
The two substrates of this enzyme are D-fructose (shown in its keto form) and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). ts products are 5-dehydro-D-fructose, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is D-fructose:NADP+ 5-oxidoreductase. Other names in common use include 5-ketofructose reductase (NADP+), 5-keto-D-fructose reductase (NADP+), fructose 5-(nicotinamide adenine dinucleotide phosphate), dehydrogenase, D-(-)fructose:(NADP+) 5-oxidoreductase, and fructose 5-dehydrogenase (NADP+).
Sources: en.wikipedia.org
=== Specialty training for interventional radiology === Training for interventional radiology occurs in the residency portion of medical education, and has gone through developments. In 2000, the Society of Interventional Radiology (SIR) created a program named "Clinical Pathway in IR", which modified the "Holman Pathway" that was already accepted by the American Board of Radiology to include training in IR; this was accepted by ABR but was not widely adopted. In 2005, SIR proposed, and ABR accepted another pathway called "DIRECT (Diagnostic and Interventional Radiology Enhanced Clinical Training) Pathway" to help trainees coming from other specialities learn IR; this too was not widely adopted. In 2006, SIR proposed a pathway resulting in certification in IR as a speciality; this was eventually accepted by the ABR in 2007 and was presented to the American Board of Medical Specialties (ABMS) in 2009, which rejected it because it did not include enough diagnostic radiology (DR) training. The proposal was reworked, at the same time that overall DR training was being revamped, and a new proposal that would lead to a dual DR/IR specialization was presented to the ABMS and was accepted in 2012 and eventually was implemented in 2014. By 2016 the field had determined that the old IR fellowships would be terminated by 2020. A handful of programs have offered interventional radiology fellowships that focus on training in the treatment of children.
=== December === 2 December – Sir Chris Wormald is appointed as the new Cabinet Secretary and Head of the Civil Service, succeeding Simon Case, and will take up the role later in December. The Ministry of Defence begins a week-long series of war games to "stress test" how the United Kingdom's military resources would cope in the event of war. It is the first such exercise to involve representatives of the defence industry, alongside military commanders and officials. Addressing the Lord Mayor's Banquet, Prime Minister Keir Starmer rejects any suggestion that the UK must choose between closer ties with the EU and the US when Donald Trump becomes president. 3 December – The Financial Times reports that South Western Railway would become the first rail operator to be renationalised when its franchise expires after Parliament passed the Passenger Railway Services (Public Ownership) Act 2024 the previous week. Andrew RT Davies resigns as leader of the Welsh Conservatives shortly after narrowly surviving a vote of confidence by Senedd members by nine votes to seven. Kevin Craig, who was suspended as Labour's election candidate for Central Suffolk and North Ipswich after placing a bet that he would lose, is cleared of wrongdoing by the Gambling Commission. A proportional representation bill to replace first-past-the-post introduced by Liberal Democrat Sarah Olney passes on a symbolic vote. Scottish Labour leader Anas Sarwar blames an "administrative mess" after one of his party's newly elected councillors was disqualified from the job.
Polonium is now usually obtained by irradiating bismuth with high-energy neutrons or protons. In 1934, an experiment showed that when natural 209Bi is bombarded with neutrons, 210Bi is created, which then decays to 210Po via beta-minus decay. By irradiating certain bismuth salts containing light element nuclei such as beryllium, a cascading (α,n) reaction can also be induced to produce 210Po in large quantities. The final purification is done pyrochemically followed by liquid-liquid extraction techniques. Polonium may now be made in milligram amounts in this procedure which uses high neutron fluxes found in nuclear reactors. Only about 100 grams are produced each year, practically all of it in Russia, making polonium exceedingly rare. This process can cause problems in lead-bismuth based liquid metal cooled nuclear reactors such as those used in the Soviet Navy's K-27. Measures must be taken in these reactors to deal with the unwanted possibility of 210Po being released from the coolant. The longer-lived isotopes of polonium, 208Po and 209Po, can be formed by proton or deuteron bombardment of bismuth using a cyclotron. Other more neutron-deficient and more unstable isotopes can be formed by the irradiation of platinum with carbon nuclei.
== Regulation == Prolactin cell regulation mainly involves dopamine, a prolactin production suppressor, estrogen, a prolactin production stimulator, and thyrotropin-releasing hormone (TRH), a prolactin release stimulator. Dopamine, the main inhibitor, keeps prolactin levels low. Dopamine is secreted by the hypothalamus during times of high prolactin levels, which in response lowers prolactin levels, a negative feedback mechanism. Estrogen, a stimulator, enhances the production of prolactin. During times of elevated estrogen levels, such as during pregnancy, prolactin production is increased. TRH stimulates the release of prolactin from the pituitary gland. TRH, also released by the hypothalamus, binds to receptors on prolactin cells, activating cellular signaling pathways that promote prolactin secretion.
Bacolod is the most populous city on the island and the center of the Bacolod Metropolitan Area (which also contains the cities of Talisay and Silay), as well as the 19th most populous city of the whole Philippines, while Dumaguete is the most densely populated city in the whole region. Negros Occidental contains 13 cities (12 component and one highly urbanized) and 19 municipalities, which are further subdivided into 601 barangays. It has the most number of chartered cities amongst all the provinces of the Philippines. Although Bacolod serves as the capital, it is governed independently from its corresponding province as a highly urbanized city. Negros Oriental comprises six cities and 19 municipalities, subdivided further into 557 barangays.
Sources: en.wikipedia.org
=== Infraclass Neopterygii === Neopterygians are the second major occurrence in the evolution of ray-finned fish and today include the majority of modern bony fish. They are distinguished from their earlier ancestors by major changes to the jaws, shape of the skull, and tail. They have three divisions:
=== Humans === The FPR3 gene was cloned and named based on the similarity of the amino acid sequence which it encodes to that encoded by the gene for FPR1 (see formyl peptide receptor 1 for details) The studies indicated that FPR3 is composed of 352 amino acids and its gene, similar to FPR1, has an intronless open reading frames which encodes a protein with the 7 transmembrane structure of G protein coupled receptors; FPR3 has 69% and 72% amino acid sequence identities with FPR1. All three genes localize to chromosome 19q.13.3 in the order of FPR1 (19q13.410), FPR2 (19q13.3-q13.4), and FPR3 (19q13.3-q13.4) to form a cluster which also includes the genes for another G protein-coupled chemotactic factor receptor, the C5a receptor (also termed CD88) and GPR77, and a second C5a receptor, C5a2 (C5L2), which has the structure of a G protein coupled receptor but fails to couple to G proteins and is of debated function.
In inhibitory synapses, the opening of either Cl- or K+ channels diminish the probability of depolarization in postsynaptic neurons and the initiation of an action potential. Astrocytes also exchange information with the synaptic neurons, responding to synaptic activity and, in turn, regulating neurotransmission.
=== General information === Adrenocortical carcinoma is extremely rare in children (approximately 0.2 to 0.3 cases per 1 million per year). The prognosis is poor. There are currently no established standards for diagnosis and treatment. Therefore, the "ENSAT kids" study group was established for children with adrenocortical carcinoma within ENSAT. While only a proportion of adrenocortical carcinomas in adults are hormonally active, almost all of these carcinomas are hormonally active in affected children. Cushing's syndrome, precocious puberty, or virilization usually occur. As with the treatment of adult patients, the tumor is completely removed surgically. If an advanced stage is present, lymph nodes are also removed in children, and chemotherapy and mitotane therapy are administered.
The Riksdag performs the normal functions of a legislature in a parliamentary democracy. It enacts laws, amends the constitution and appoints a government. In most parliamentary democracies, the head of state commissions a politician to form a government. Under the new Instrument of Government (one of the four fundamental laws of the Constitution) enacted in 1974, that task was removed from the monarch of Sweden and given to the speaker of the Riksdag. To make changes to the Constitution under the new Instrument of Government, amendments must be approved twice, in two successive electoral periods with a regular general election held in between. There are 15 parliamentary committees in the Riksdag.
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.